The present invention particularly relates to a newly identified murine genomic polynucleotide that encodes an ortholog of the human P2T receptor which is expressed at high levels in the central nervous system, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. The invention relates also to identifying compounds which may be agonists, antagonists and/or inhibitors of P2T, and therefore potentially useful in therapy.

 
Web www.patentalert.com

< Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil

< Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria

> Methods for selecting nucleic acid probes

> Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility

~ 00291